CAPLIPOINT2,792.00

Caplin Point Laboratories Ltd.

· Pharma & Health
₹ CrorePeersAJANTPHARMERISGLANDBLUEJETCONCORDBIOACUTAASEMCUREGRANULESMcap ₹21,219 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation53.466.072.8
+ Finance Costs0.80.60.9
+ Interest Income-47.3-63.6-77.6
+ Fair Value (Gains) / Losses-0.9-5.0-2.1
+ Share-based Payments0.90.00.0
+ Unrealised FX (Gain) / Loss-0.9-3.50.0
+ Other Non-cash Items11.534.3117.4
+ Other — Cash Effects are Investing / Financing0.03.84.2
Changes in Working Capital
+ Inventories-74.826.9-92.8
+ Trade Receivables — Current-148.7-87.8-178.7
+ Other Financial Assets — Current-1.4-2.3-3.4
+ Other Current Assets-2.6-54.3-44.5
+ Trade Payables — Current69.3-28.869.0
Cash from Operating Activities
Profit Before Tax (per I/S)564.4676.8802.8843.6
+ Total Adjustments (incl. Working Capital)-140.6-113.8-135.1
Cash from Operations (pre-tax)423.8563.0667.7
+ Other Inflows / (Outflows) — Operating-3.70.00.0
+ Income Taxes Paid109.2130.6144.5
Cash from Operating Activities311.0432.4523.2
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)145.8191.5248.1
+ Purchase of Investments (Equity / Debt)93.8213.8268.3
+ Interest Received — Investing43.751.762.4
+ Other Inflows / (Outflows) — Investing-116.818.8-128.3
Cash from Investing Activities-312.6-334.7-582.3
Cash from Financing Activities
+ Proceeds from Exercise of Stock Options0.00.00.0
+ Proceeds from Borrowings-3.10.30.0
+ Interest Paid0.80.60.9
+ Dividends Paid34.238.045.6
Cash from Financing Activities-38.1-38.3-46.5
Net Changes in Cash (pre-FX)-39.759.3-105.5
+ Effect of FX Rate Changes on Cash0.90.00.3
Net Changes in Cash-38.959.3-105.3
Closing Cash138.7
Reference Items
EBITDA551.4646.9760.9796.6
EBITDA Margin %32.5533.3934.7934.83
Free Cash Flow (CFO − Capex)165.2240.9275.1275.1
Free Cash Flow to Equity239.6274.3
Free Cash Flow per Basic Share21.7331.6936.2036.20
Price to Free Cash Flow77.13
Cash Flow to Net Income0.670.800.81
Cash Paid for Taxes109.2130.6144.5
Cash Paid for Interest0.80.60.9
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.